There is no currently successful method to treat Covid-19 infection. Nevertheless, previously
licensed pharmaceuticals to treat other virus infections are used on an off-label basis either …

Favipiravir (FVP), a pyrazine analog, has shown antiviral activity against a wide variety of
viruses. It is considered to be worth further investigation as a potential candidate drug for …

Abstract Introduction. Coronavirus disease (COVID-19) is an acute infectious disease
caused by SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus 2) …

Hplc method has been developed and validated for the quantification of Favipiravir in tablet
formulation The chromatographic separation was achieved by using Luna® Phenomenex …

Objective: A simple spectrophotometric method has been proposed for quantitative analysis
of favipiravir in bulk and pharmaceutical dosage form. Methods: New Fourier transform …

A precise, simple and reproducible reverse phase liquid chromatography (RP-HPLC)
method was developed and validated for determination of Favipiravir by using …

Favipiravir is antiviral drug and nowadays it is part of treatment of covid 19. The aim of the
research work was to develop a validated simple, sensitive, precise and specific high …

Simple, accurate and robust analytical methods have been developed and validated for the
determination of favipiravir (FVPR) by RP-HPLC and UV spectroscopy techniques as per the …

Aims: To develop and validate a new, simple, rapid, precise, and accurate An Eco-friendly
RP-HPLC and UV-Method Development and Validation for an estimation of Favipiravir in …

Favipiravir is a broad-spectrum inhibitor of viral RNA polymerase. It is currently used as a
possible treatment for coronavirus disease 2019 (COVID-19). Pre-clinical or clinical trials of …